The Yale Alzheimer's Disease Research Unit (ADRU) conducts clinical research in the treatment, neuroimaging and genetics of Alzheimer's disease and healthy aging. A complete list of current clinical trials is available at www.alzheimers.yale.edu/clinical_trials.html. The ADRU is a member site of the Alzheimer's Disease Cooperative Study (ADCS) funded by the National Institute of Aging (NIA) and also conducts treatment studies in collaboration with industry. Treatment is provided free of charge for patients who voluntarily participate in treatment studies. Additional research interests include neuroimaging in Alzheimers disease and healthy aging (in collaboration with the Yale PET Center and the Magnetic Resonance Research Center) and genetic studies of Alzheimers disease.
|van Dyck, Christopher H, MD||Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit||(203) 764-8100 Appts
(203) 764-8111 Fax